The Europe surgical site infection control market is estimated to grow with a CAGR of 5.76%, during the forecast period of 2021 to 2028. The region’s market growth is fueled by the growing prevalence of surgical site infections, and the rising research and development activities. The Europe surgical site infection control market growth is evaluated by analyzing the United Kingdom, Germany, Italy, Belgium, France, Russia, Poland, and the rest of Europe.
EUROPE SURGICAL SITE INFECTION CONTROL MARKET FORECAST 2021-2028
Europe Surgical Site Infection Control Market by Procedure (Laparoscopy, Orthopedic Surgery, Cardiovascular, Obstetrics and Gynecology, Wound Closure, Plastic & Reconstructive Surgery, Thoracic Surgery, Microvascular, Urology, Neurosurgery, Other Procedures) by Type of Infection (Superficial Incisional Ssi, Deep Incisional Ssi, Organ or Space Ssi) by End-user (Hospitals, Ambulatory Surgical Centers) by Product (Disinfectants, Manual Reprocessors Solution, Surgical Drapes, Surgical Gloves, Skin Preparation Solution, Surgical Irrigation, Surgical Scrubs, Hair Clippers, Medical Nonwovens, Other Products) and by Geography.
The Europe surgical site infection control market is estimated to grow with a CAGR of 5.76%, during the forecast period of 2021 to 2028. The region’s market growth is fueled by the growing prevalence of surgical site infections, and the rising research and development activities.
To learn more about this report, request a free sample copy
The Europe surgical site infection control market growth is evaluated by analyzing the United Kingdom, Germany, Italy, Belgium, France, Russia, Poland, and the rest of Europe. As per Public Health England (PHE), surgical site infections accounted for nearly 16% of all healthcare-associated infections, in England, in 2013. Moreover, surgical site infections are among the most commonly observed condition linked to healthcare, across the United Kingdom. The PHE report also asserted the increasing trend of surgical site infections at a national level, primarily for patients undergoing procedures, such as, knee prosthesis, large bowel, as well as cholecystectomy surgery. Besides, at least 50% of the surgical site infection’s causative pathogens were meticillin-sensitive Staphylococcus aureus (MSSA) and Enterobacteriaceae.
Conversely, according to the World Health Organization (WHO), surgical site infections are one of the most frequent nosocomial infections observed in Germany. For instance, colon surgery is associated with the highest rates of such infections, accounting for over 7%, of all surgeries. Thus, projects aiming to build prevention networks through technology and interventions in the EUREIGO (Germany and the Netherlands), are continually rising due to the growing incidence of surgical site infections. Hence, these factors are set to drive market growth.
Biomeriux SA, headquartered in France, offers products and solutions linked to diagnosing and managing infectious diseases, targeted cancers, and cardiovascular conditions. It also provides solutions for detecting specific pathogen bacteria, enumerating microbial flora, and monitoring air and surface quality, among others.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- INCREASING RATE OF SURGERIES
- SURGE IN GERIATRIC POPULATION
- IMPLEMENTATION OF REGULATORY GUIDELINES FOR THE PREVENTION OF HOSPITAL ACQUIRED INFECTION
- INCREASED INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
- KEY RESTRAINTS
- SURGING MEDICAL WASTE DUE TO THE USE OF MEDICAL DISPOSABLE ITEMS
- RISE IN THE USE OF OUTPATIENT TREATMENTS
- KEY DRIVERS
- KEY ANALYTICS
- PORTER’S FIVE FORCE ANALYSIS
- THREAT OF NEW ENTRY
- THREAT OF SUBSTITUTION
- BUYER’S POWER
- SUPPLIER’S POWER
- COMPETITIVE RIVALRY
- IMPACT OF COVID-19 ON SURGICAL SITE INFECTION CONTROL MARKET
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- KEY INVESTMENT INSIGHTS
- PORTER’S FIVE FORCE ANALYSIS
- MARKET BY PROCEDURE
- LAPAROSCOPY
- ORTHOPEDIC SURGERY
- CARDIOVASCULAR
- OBSTETRICS AND GYNECOLOGY
- WOUND CLOSURE
- PLASTIC & RECONSTRUCTIVE SURGERY
- THORACIC SURGERY
- MICROVASCULAR
- UROLOGY
- NEUROSURGERY
- OTHER PROCEDURES
- MARKET BY TYPE OF INFECTION
- SUPERFICIAL INCISIONAL SSI
- DEEP INCISIONAL SSI
- ORGAN OR SPACE SSI
- MARKET BY END-USER
- HOSPITALS
- AMBULATORY SURGICAL CENTERS
- MARKET BY PRODUCT
- DISINFECTANTS
- MANUAL REPROCESSORS SOLUTION
- SURGICAL DRAPES
- SURGICAL GLOVES
- SKIN PREPARATION SOLUTION
- SURGICAL IRRIGATION
- SURGICAL SCRUBS
- HAIR CLIPPERS
- MEDICAL NONWOVENS
- OTHER PRODUCTS
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- GERMANY
- UNITED KINGDOM
- FRANCE
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- EUROPE
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGER & ACQUISITIONS
- PRODUCT LAUNCH & DEVELOPMENTS
- PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
- BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
- COMPANY PROFILES
- 3M COMPANY
- AMERICAN POLYFILM
- ANSELL LTD
- BECTON, DICKINSON AND COMPANY (BD)
- BELIMED AG
- BIOMERIEUX SA
- GAMA HEALTHCARE
- GETINGE AB
- JOHNSON & JOHNSON
- KIMBERLY-CLARK
- LAC-MAC
- PACON MANUFACTURING CORPORATION
- SOTERA HEALTH LLC
- STERIS CORPORATION
- STRYKER CORPORATION
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – SURGICAL SITE INFECTION CONTROL
TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER, 2019 AND 2050
TABLE 3: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 4: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 5: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 6: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 7: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 8: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 10: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 11: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, HISTORICAL YEARS 2016-2020 (IN $ MILLION)
TABLE 12: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 13: LEADING PLAYERS OPERATING IN EUROPE SURGICAL SITE INFECTION CONTROL MARKET
LIST OF FIGURES
FIGURE 1: COMMON TYPES OF HAIS
FIGURE 2: PORTER’S FIVE FORCE ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: KEY INVESTMENT INSIGHTS
FIGURE 6: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, IN 2020
FIGURE 7: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
FIGURE 8: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY UROLOGY, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2021-2028 (IN $ MILLION)
FIGURE 17: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)
FIGURE 18: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, IN 2020
FIGURE 19: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE 20: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2021-2028 (IN $ MILLION)
FIGURE 22: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, IN 2020
FIGURE 23: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 24: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
FIGURE 25: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, IN 2020
FIGURE 26: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2021-2028 (IN $ MILLION)
FIGURE 27: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTION, 2021-2028 (IN $ MILLION)
FIGURE 28: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2021-2028 (IN $ MILLION)
FIGURE 29: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2021-2028 (IN $ MILLION)
FIGURE 30: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTION, 2021-2028 (IN $ MILLION)
FIGURE 31: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2021-2028 (IN $ MILLION)
FIGURE 32: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2021-2028 (IN $ MILLION)
FIGURE 33: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2021-2028 (IN $ MILLION)
FIGURE 34: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2021-2028 (IN $ MILLION)
FIGURE 35: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE 36: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 37: GERMANY SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
FIGURE 38: UNITED KINGDOM SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
FIGURE 39: FRANCE SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
FIGURE 40: ITALY SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
FIGURE 41: RUSSIA SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
FIGURE 42: BELGIUM SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
FIGURE 43: POLAND SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
FIGURE 44: REST OF EUROPE SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- GERMANY
- UNITED KINGDOM
- FRANCE
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- EUROPE
- MARKET BY PROCEDURE
- LAPAROSCOPY
- ORTHOPEDIC SURGERY
- CARDIOVASCULAR
- OBSTETRICS AND GYNECOLOGY
- WOUND CLOSURE
- PLASTIC & RECONSTRUCTIVE SURGERY
- THORACIC SURGERY
- MICROVASCULAR
- UROLOGY
- NEUROSURGERY
- OTHER PROCEDURES
- MARKET BY TYPE OF INFECTION
- SUPERFICIAL INCISIONAL SSI
- DEEP INCISIONAL SSI
- ORGAN OR SPACE SSI
- MARKET BY END-USER
- HOSPITALS
- AMBULATORY SURGICAL CENTERS
- MARKET BY PRODUCT
- DISINFECTANTS
- MANUAL REPROCESSORS SOLUTION
- SURGICAL DRAPES
- SURGICAL GLOVES
- SKIN PREPARATION SOLUTION
- SURGICAL IRRIGATION
- SURGICAL SCRUBS
- HAIR CLIPPERS
- MEDICAL NONWOVENS
- OTHER PRODUCTS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.